Summary As yet, there is no reported study of chromosome allele loss in fibrolamellar carcinoma (FLC), a distinct, rare variant of hepatocellular carcinoma (HCC). We searched for evidence of allele loss in FLC using 18 DNA probes for 10 chromosomes and compared the pattern of loss with our series of HCC. Two of the probes, AMS32 (lq42-43) and cMS621 (5p) showed allele losses in one tumour, while other probes showed no loss. The frequency of allele loss in FLC was much lower than in HCC, which may be associated with their different prognoses.
Fibrolamellar carcinoma (FLC) is a rare variant of hepatocellular carcinoma (HCC). It occurs in younger patients (20-30 years) with an equal sex incidence. Cirrhosis and hepatitis B virus (HBV) infections are rarely seen in patients with FLC and it is thought that the tumour may arise from areas of focal nodular hyperplasia (Vecchio et al., 1984) . The prognosis of patients with FLC is better than that of HCC with an average survival of 44 months compared to 6 months in HCC (Craig et al., 1980) . It is these differences in clinicopathological features which would suggest that FLC and HCC have a different pathogenesis.
Genes which are involved in tumorigenesis appear to belong to two classes, the cellular oncogenes and tumour suppressor genes. Normally, cell proliferation is controlled by a balance between growth-promoting proto-oncogenes and growth-limiting tumour suppressor genes. Malignant activation of the former occurs by point mutation, transposition or amplification, whereas loss of function in the latter group can be caused by complete gene deletion as well as by intragenic mechanisms (Aaronson, 1991; Weinberg, 1991 (Lasko et al., 1991) , and the frequency may be positively correlated with clinical prognosis, for example in colorectal cancer (Vogelstein et al., 1989) .
Recently, we and others have studied the pattern of chromosome allele loss (loss of genetic material) in HCC (Ding et al., 1991; Zhang et al., 1990; Fujimori et al., 1991 DNA extraction and analysis DNA was prepared from blood and tissue samples by standard phenol/chloroform methods (Sambrook et al., 1989) .
Southern analyses were done as previously described (Ding et al., 1991) . The 18 RFLP probes for chromosomes 1, 5, 7, 9, 11, 12, 13, 16, 17 and 18 and the appropriate restriction enzymes are listed in Table II . These 18 probes were those used in the previous study on HCC (Ding et al., 1991) , including probes screening regions near or flanking loci of most known tumour suppressor genes (Table II) . If two alleles appeared as two separate bands in the resultant autoradiograph of the constitutional DNA, the patient was considered 'informative', or heterozygous, for the particular marker. Complete deletion or great loss of intensity of one band in the tumour DNA indicated an allele loss.
Statistical analysis
The significance of the difference in the frequency of allele loss was tested by a standard method for comparison of proportions (Bland, 1987) . Figure 1 shows the two allelic losses, both of which occurred in a single patient (No. 3). Only that patient had a recurrent FLC (Table I ). The chromosomal regions deleted in his tumour were lq42-43 detected by the probe AMS32 and 5p by cMS621. These two probes also showed a high frequency of allele loss in HCC with liver cirrhosis, as previously reported (Ding et al., 1991) . Patient No. 4 had a synchronous HCC. The HCC of this patient had an allele loss detected by the probe AMS 43 (12q24.3-qter), but his FLC had no similar allele loss ( Figure  2 ). The probe was informative also in all the other four patients but showed allele loss in none of them (Table II) .
Results

Discussion
This study showed that the frequency of allele loss in fibrolamellar carcinoma was very low (2/55, 3.6%). With the same method, we found a much higher frequency of allele loss in HCC (30/186, 16.1%) (Ding et al., 1991) . For colorectal carcinomas, patients with a higher frequency of allelic losses had a considerably worse prognosis than did the other patients (Vogelstein et al., 1989) . A similar correlation was observed in carcinomas of the pancreas (Ding et al., 1992) . Thus this study showing a much lower frequency of allele loss in FLC than in HCC is in agreement with the above observations since FLC has a much better prognosis than HCC (Craig et at., 1980) . Of the five patients with FLC in this study, the FLC with two allelic losses recurred while the others did not (Table I) .
Previously, we reported that in HCC with liver cirrhosis the highest frequency of allele loss occurred in chromosomal regions lq42-43, Sp and 17pl3, These results may for the first time show the differences in genetic background in these two primary liver cancers, in addition to their clinico-pathological differences.
